Patients harbouring a pathogenic variant in the MCT8 encoding gene SLC16A2 exhibit severe clinical features known as MCT8 deficiency or Allan–Herndon–Dudley syndrome [7–9]. The gene discussed is SLC16A2; the disease is hyperinsulinemic hypoglycemia, familial, 4.